The Venture Codex Logo

The Venture Codex

Biomatics Capital

188 E Blaine Street, Ste 126, Seattle, WA, 98102, United States

Overview

Venture firm investing in early-stage healthcare and life sciences.

Founded

2016

Deals ยท 12mo

0

Links

WebsiteLinkedIn

Stage focus

Series A
Series B
Series C

Geographic focus

United States

Sector focus

Biotechnology
Health Care
Life Science
Venture Capital

Investment portfolio

19rounds
NAMEDATESIZE
Encodia
Jan 2021Participated
$75 MSeries C
Verve Therapeutics
Jan 2021Participated
$94 MSeries B
Verve Therapeutics
Jun 2020Participated
$63 MSeries A
Omniome
Jan 2020Participated
$60 MSeries C
AiCure
Nov 2019Participated
$25 MSeries C
EGenesis
Nov 2019Participated
$100 MSeries B
BlackThorn Therapeutics
Jun 2019Participated
$76 MSeries B
Thrive Earlier Detection
May 2019Participated
$110 MSeries A
Verve Therapeutics
May 2019Participated
$59 MSeries A
Verana Health
Jul 2018Participated
$30 MSeries C
Omniome
Jul 2018Participated
$60 MSeries B
Compass Therapeutics, Inc.
Jul 2018Participated
$49 MSeries A
Encodia
Jan 2021Participated
$75 MSeries C
Verve Therapeutics
Jan 2021Participated
$94 MSeries B
Verve Therapeutics
Jun 2020Participated
$63 MSeries A
Omniome
Jan 2020Participated
$60 MSeries C
AiCure
Nov 2019Participated
$25 MSeries C
EGenesis
Nov 2019Participated
$100 MSeries B
BlackThorn Therapeutics
Jun 2019Participated
$76 MSeries B
Thrive Earlier Detection
May 2019Participated
$110 MSeries A
Verve Therapeutics
May 2019Participated
$59 MSeries A
Verana Health
Jul 2018Participated
$30 MSeries C
Omniome
Jul 2018Participated
$60 MSeries B
Compass Therapeutics, Inc.
Jul 2018Participated
$49 MSeries A
19
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Biomatics Capital: 19 funding rounds are recorded in the selected participation categories.All available history.
Biomatics Capital: 19 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A16
Series B15
Series C+05
Other Equity01

Monthly Deal Activity

Biomatics Capital: 19 deals are recorded across 130 months.All available history.
Biomatics Capital: 19 deals are recorded across 130 months. All available history
MonthDeals
Jan '161
Feb '160
Mar '160
Apr '160
May '160
Jun '160
Jul '160
Aug '160
Sep '160
Oct '160
Nov '160
Dec '160
Jan '172
Feb '170
Mar '171
Apr '170
May '170
Jun '171
Jul '170
Aug '170
Sep '170
Oct '170
Nov '170
Dec '171
Jan '180
Feb '180
Mar '180
Apr '180
May '180
Jun '181
Jul '183
Aug '180
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '192
Jun '191
Jul '190
Aug '190
Sep '190
Oct '190
Nov '192
Dec '190
Jan '201
Feb '200
Mar '200
Apr '200
May '200
Jun '201
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '212
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Biomatics Capital: Health & Life Sciences is the largest displayed sector by deal count (19 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Biomatics Capital: Health & Life Sciences is the largest displayed sector by deal count (19 deals). All available history
SectorDeals
Health & Life Sciences19
AI & Machine Learning4
Data, Analytics & IT3
Space & Frontier Tech2
Enterprise Software1

Deal Size Distribution

Biomatics Capital: 19 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Biomatics Capital: 19 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M5
$25M-$50M5
$50M-$100M7
$100M-$250M2
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Biomatics Capital: United States has the largest recorded deal count among the displayed regions (19 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Biomatics Capital: United States has the largest recorded deal count among the displayed regions (19 deals). All available history
RegionDeals
United States19
Biomatics Capital: 20 co-investors are shown, with ARCH Venture Partners sharing 10 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Biomatics Capital: 20 co-investors are shown, with ARCH Venture Partners sharing 10 recorded deals. All available history
Co-investorShared deals
ARCH Venture Partners10
Google Ventures8
Alexandria Venture Investments4
Altitude Life Science Ventures3
Casdin Capital3
Decheng Capital3
F-Prime Capital3
Nan Fung Life Sciences3
Alta Partners2
Domain Associates2
Khosla Ventures2
New Leaf Venture Partners2
Tribeca Venture Partners2
Venrock2
Wellington Management2
3W Partners1
Accelmed1
Asahi Kasei1
Baird Capital1
Bay City Capital1

Investment Strategy

Biomatics Capital: Led accounts for 11% and participating for 89% of round participation.All available history.
Biomatics Capital: Led accounts for 11% and participating for 89% of round participation. All available history
CategoryDeals (count)Share (%)
Led211%
Participating1789%
Biomatics Capital: Single-lead accounts for 50% and co-led for 50% of lead dynamics.All available history.
Biomatics Capital: Single-lead accounts for 50% and co-led for 50% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead150%
Co-led150%

Team

Boris Nikolic

Co-Founder & Managing Director

Julie Sunderland

Managing Director